 |
recombinant humanized anti-matrix metalloprotein 9 (MMP9) monoclonal antibody IgG4 |
|---|---|
| Trade Name | |
| Orphan Indication | Stomach Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-07-16 00:00:00 |
| Sponsor | Gilead Sciences, Inc.;199 E. Blaine St.;Seattle, Washington, 98102 |
Related Access Program